Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Venus Remedies enters into Partnership with West Pharmaceutical Services,Inc. to Launch Cloti-Xa™ in India with NovaGuard' SA Pro Safety System

Posted On: 2021-04-13 02:16:33 (Time Zone: Arizona, USA)


Venus Remedies Limited is a research and development driven global pharmaceutical company and among the leading injectable manufacturers in the world, recently announced its partnership with West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, for its new introduction in the fast-growing low molecular weight heparin market with brand Cloti-Xa™, which has adopted NovaGuard@ SA Pro safety system, a single-use accessory for prefilled ISO standard 1mL long staked-needle syringes.

Cloti-Xa™ which contains enoxaparin sodium is being introduced with added advantage of NovaGuardo SA Pro safety system which is a revolutionary product that helps and protects healthcare workers and patients from accidental needlestick injuries. This innovative product has been commented to deliver a compelling total cost of ownership in that it prevents preactivation, offers a lower syringe snap-in force and a lower activation force for end-user comfort, and mitigates the practice of recapping which helps to provide tamper evidence to customers.

Mr. Saransh Chaudhary, Chief Executive Officer, Venus Medicine Research Centre said, "We are delighted to enter into a partnership with West to produce Cloti-Xa™ PFS with the innovative NovaGuard@ SA Pro safety system in India - Cloti-Xa™ is expected to provide patients and healthcare providers with an additional advantage of safety fiom accidental needle stick injuries, which could lead to the spread ofinfections like HIV, HepatitiS B and C. So far, no other enoxaparin formulation in India seems to offer this additional benefit apart from the innovator brand. Enoxaparin use has increased significantly in ICUs after it has been found useflrl in reducing hospitalization and mortality in COVID-l9 patients. I am positive that it is going to be a high yielding addition to our portfolio, and we intend to add more such innovative products iny'o our product line."

The NovaGuard@ SA Pro safety system in Cloti-Xa™:

- Has been designed to prevent pre-activation during handling;
- Includes tamper-resistant functionality;
- Provides transparency for drug inspection and labeling;
- Is easy to use for healthcare practitioners as it does not require any change in drug administration technique;
- Helps in reducing needlestick injuries and improve OSHA compliance

Speaking on the partnership, Mr. Alagu Subrananiam, Managing Director, West India said, "we are excited to extend our partnership with Venus Remedies on this new product launch. By delivering unique and innovative packaging products and services, we at West are committed to improving patients' health. This partnership helps us bring the benefits of our innovative NovaGuard@ SA Pro safety system to the India market and we will continue to extend the range ofour innovative products to local customers and patients worldwide."

The NovaGuard@ SA Pro lml- safety system has FDA 510k clearance in the U.S. and meets the European 2010/32/EU directive for the prevention of sharps injuries. Designed for both cut and circular syringe flange, the NovaGuard@ SA Pro safety system has design features that lock when used and has minimal impact upon syringe filling lines.

The NovaGuard@ SA Pro safety system has also won the India Packaging Awards for Excellence in Enhanced User Experience and Excellence in Packaging Design - Shapes and Structures during the UBM InnoPack Pharma Conference's India Packaging Awards ceremony.

Shares of VENUS REMEDIES LTD. was last trading in BSE at Rs.276 as compared to the previous close of Rs. 287.5. The total number of shares traded during the day was 13521 in over 656 trades.

The stock hit an intraday high of Rs. 288 and intraday low of 274. The net turnover during the day was Rs. 3726610.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Other Headlines:

Aarti Industries Ltd board approves fund raising proposal

PI Industries Limited board recommends final dividend of Rs. 2

Power Finance Corporation Limited arm forms two SPVs

Aarti Industries Limited board recommends 1:1 bonus issue

PI Industries Ltd Q4FY21 consolidated PAT at Rs. 179.8 crore

Chalet Hotels Ltd board approves issue of NCDs, NCNCRPS

Aarti Industries Ltd board recommends final dividend of Rs. 3

NLC India Limited announces shut down of Unit 5

Aarti Industries Ltd Q4FY21 consolidated net profit at Rs. 136.10 crore

Chalet Hotels Ltd to repurpose Sahar Mumbai Retail Mall into Commercial Office space

Ester Industries Ltd Board approves final dividend of Rs. 1.90

GlaxoSmithKline Pharmaceuticals Ltd board recommends dividend of Rs. 30

Chalet Hotels Ltd reports Q4 and FY21 results

Ester Industries Ltd Q4FY21 PAT at Rs. 33.88 crore

GlaxoSmithKline Pharmaceuticals Limited Q4FY21 consolidated net profit at Rs. 14.33 crore

Vi announces Covid-19 Special Relief Offers for 60 Mn Low Income Users

Edelweiss General Insurance launches IPOS, an end to end partner onboarding solution

Exide Life Insurance launches 'Guaranteed Wealth Plus', a Savings Plan with Unmatched Income and Guaranteed Maturity Benefits

Minda Corporation Ltd board recommends final dividend of Rs. 0.35

Inventure Growth & Securities Ltd to launch zero brokerage online trading platform

Minda Corporation Ltd Q4FY21 consolidated net profit at Rs. 12.92 crore

Torrent Pharmaceuticals Ltd reports Q4FY21 consolidated PAT of Rs. 324 crores

Gujarat Alkalies and Chemicals Ltd Board approves Dividend of Rs. 8

Brigade Enterprises Ltd board recommends final dividend of Rs. 1.20

Karur Vysya Bank donates Rs. 1.00 crore to the Tamil Nadu State Disaster Management Authority from its CSR funds

Gujarat Alkalies and Chemicals Ltd Q4FY21 consolidated PAT up at Rs. 34.66 crore

Brigade Enterprises Ltd Q4FY21 consolidated net profit at Rs. 39.57 crore

Majesco Collaborates with Infosys to Accelerate Digital Experience for Insurers

Ujjivan Small Finance Bank Ltd reports earnings for Q4FY21, FY2021

Shilp Gravures Ltd Board recommends dividend of Rs. 1.80

Opus Capital Markets Consultants Now Wipro Opus Risk Solutions

Shri Bajrang Alliance Ltd opens 3 new retail stores at Chandigarh

Umang Dairies Ltd Board recommends Dividend of Rs. 0.50

Torrent Pharmaceuticals Ltd Board recommends Final Dividend of Rs. 15

Astral Ltd Board approves final dividend of Rs. 1

Shilp Gravures Ltd Q4FY21 consolidated PAT declines QoQ to Rs. 1.45 crore

Upsurge Investment & Finance Ltd posts PAT of Rs. 2.21 crore in Q4FY21

Tata Motors Ltd posts Rs. 7605.40 crores consolidated loss in Q4FY21

Jindal Stainless (Hisar) Limited posts Q4FY21 consolidated PAT of Rs. 349.95 crore

Umang Dairies Ltd Q4FY21 loss at Rs. 1.02 crore

JSL Industries Ltd reports PAT of Rs. 0.09 crore in Q4FY21

Astral Ltd Q4FY21 consolidated PAT jumps to Rs. 174.6 crore

Coromandel Engineering Company Ltd posts PAT of Rs. 2.52 crore in Q4 FY2020-21

Century Enka Ltd board approves investment of Rs. 240 crores capex

Route Mobile Ltd board recommends dividend of Rs. 2

Pioneer Embroideries Ltd board recommends dividend of Rs. 0.25

Century Enka Ltd Board recommends Dividend of Rs. 8

Route Mobile Ltd Q4FY21 consolidated PAT falls QoQ to Rs. 35.36 crore

Pioneer Embroideries Ltd Q4FY21 consolidated PAT up at Rs. 10.57 crore

Jyothy Labs Ltd Board approves dividend of Rs. 4


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020